en

PRODUCT DETAIL

Sodium glycerophosphate Pharm-In

Code 6948E
MA number 39/0167/24-S
Product Form: con inf 20x20 ml (amp.PP)
MA Status: R - Valid Marketing Authorisation
Type of procedure: National
MAH, country: Fresenius Kabi s.r.o., Czechia
Therapeutic Class: 39 - SOLI A IONTY PRO P.O. A PARENT. APLIKÁCIU
ATC:
B BLOOD AND BLOOD FORMING ORGANS
B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B05X I.V. SOLUTION ADDITIVES
B05XA Electrolyte solutions
B05XA14 Sodium glycerophosphate
Shelf life: 36
Container: ampoule PP
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10a well-established use application
MA issued: 14.08.2024
Validity: 14.08.2029
Pediatric indication: Yes
Pediatric posology: Yes
PIL: PIL_Sodium glycerophosphate Fresenius_09_2024.pdf  
SPC: SPC_Sodium glycerophosphate Fresenius_09_2024.pdf  
Safety feature No
Data update: 15.08.2024
eu-flag.png sk-flag.png